Nancy Miller-Rich

Currently holds a position at Intercept Pharmaceuticals Inc

1.5

1.5

Position	Company	Period
Independent Director	Intercept Pharmaceuticals Inc	April 24, 2018 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Aldeyra Therapeutics Inc (ALDX)

Transaction date 12 Apr 2023

Purchase

Price

178.17

Quantity 61,643 -6.2%

Value US$218,339

Comments Filing

Aldeyra Therapeutics Inc (ALDX)

Transaction date 3 May 2021

Purchase

Price

60.89

Quantity 5,020 +10.9%

Value US$2,940,968

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2024-10-21	2023-04-12	Aldeyra Therapeutics Inc (ALDX)	B Purchase	61,643 -6.2% 178.17 US$218,339	61,643 -6.2%	178.17	US$218,339
2024-10-21	2021-05-03	Aldeyra Therapeutics Inc (ALDX)	B Purchase	5,020 +10.9% 60.89 US$2,940,968	5,020 +10.9%	60.89	US$2,940,968